Influence on early outcome and restenosis of urokinase before elective coronary angioplasty
| Autor: | Bernhard Meier, Vivek K. Mehan, Philip Urban |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Premedication Coronary Disease Restenosis Double-Blind Method Recurrence Angioplasty Internal medicine Occlusion medicine Thrombolytic Agent Humans Angioplasty Balloon Coronary Aged Urokinase Aged 80 and over Aspirin business.industry Vascular disease Heparin Coronary Thrombosis Middle Aged medicine.disease Thrombosis Urokinase-Type Plasminogen Activator Surgery Stenosis Treatment Outcome Cardiology Female Cardiology and Cardiovascular Medicine business medicine.drug Follow-Up Studies |
| Zdroj: | The American journal of cardiology. 72(1) |
| ISSN: | 0002-9149 |
| Popis: | Thrombosis at the site of coronary angioplasty is responsible for abrupt occlusion after angioplasty 1,2 . The thrombotic process may also promote the excessive myointimal proliferation that leads to restenosis 3,4 . To assess whether a thrombolytic agent would ameliorate these consequences of thrombosis at the site of dilatation, we evaluated the early and late outcomes of urokinase therapy before routine angioplasty. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|